期刊文献+

葡萄糖转运蛋白1在恶性胸腔积液的表达及意义

Expression of GLUT-1 in malignant pleural effusion and its clinical significance
下载PDF
导出
摘要 目的评价葡萄糖转运蛋白l(GLUT-1)在恶性胸腔积液中的诊断价值。方法采用免疫细胞化学SP法检测肿瘤性和非肿瘤性胸腔积液中脱落细胞GLUT-1的表达以及ELISA法测定胸水中GLUT-1的水平。结果两组胸液脱落细胞GLUT-1的表达率恶性组为89.33%,良性组为3.17%,两组间具有统计学差异(P<0.01);两组胸液上清中GLUT-1的表达水平恶性组为(1.18±0.35)pg/ml,良性组为(0.85±0.24)pg/ml,两组间具有统计学差异(P<0.05)。结论 GLUT-1对恶性胸腔积液的诊断具有较高的敏感度,可以作为鉴别恶性胸腔积液的可靠标记之一。 Objective To investigate the diagnostic value of glucose transporter-1 ( GLUT-1 ) in malignant pleural effusion. Methods The levels of GLUT-1 in neoplastic pleural effusion and non-neoplastic pleural effusion exfoliated cells were determined by immunohistochemistry SP method, and the levels of GLUT-1 in pleural effusion serum were detected by enzyme-linked immunosorbent assay. Results The expression of GLUT-1 of pleural effusion exfoliated cells in the malignant group was 89. 33% and 3. 17% in the benign group (P 〈0. 01). the levels of GLUT-1 of pleural effusion serum t were (1. 18 ± 0. 35) pg/ml in the malignant group and (0. 85 ± 0. 24) pg/ml in the benign group (P〈0. 05). Conclusion GLUT-1 has a higher sensitivity in diagnosis of malignant pleural effusions, which can be used as a reliable marker in identification of malignant pleural.
作者 孙晓静
出处 《临床肺科杂志》 2015年第6期1012-1015,共4页 Journal of Clinical Pulmonary Medicine
关键词 葡萄糖转运蛋白1 胸腔积液 肿瘤 肿瘤标志物 glucose transporter-1 pleural effusion tumor tumor makers
  • 相关文献

参考文献6

二级参考文献55

  • 1韦毓,庞朗,冯秀英.子宫内膜样腺癌及癌前病变组织中PTEN、cyclin E蛋白的表达[J].临床与实验病理学杂志,2006,22(6):728-729. 被引量:1
  • 2Alatas F,Alatas O,Metintas M,et al.Diagnostic value of CEA,CA 15-3,CA 19-9,CYFRA 21-1,NSE and TSA assay in pleural effusions [J]. Lung Cancer,2001,31( 1 ) :9-16.
  • 3Porcel JM, Vires M, Esquerda A, et al.Use of a panel of tumor mark- (carcinoembryonic antigen,cancer antigen 125,carbohydrate antigenl5-3,and cytokeratin 19 fragments)in pleural fluid for the differential diagnosis of benign and malignant effusions [J ].Chest, 2004,126(6): 1757-1763.
  • 4Ueda J, Iwata T, Ono M, et al.Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion [J ].Diagu Cytopathol, 2006,34( 1 ) : 6-10.
  • 5Lee JH, Chang JH.Diagnostic utility of serum and pleural fluid carcinoembryonie antigen,neuron-specific enolase,and eytokeratin 19 fragments in patients with effusion from primary lung cancer [J]. Chest, 2005 ; 128 (4) : 2298-2303.
  • 6Afify AM, Stern R, Michael CW. Differentiation of mesothelioma from adenocarcinoma in serous effusions:the role of hyaluronic acid and CD44 localization [ J ].Diagn Cytopathol, 2005,32( 3 ) : 145-150.
  • 7Afify A, Zhou H, Howell L, et al.Diagnostic utility of GLUT- 1 expression in the cytologic evaluation of serous fluids [J ]. Acta Cytol,2005,49 (6) :621-626.
  • 8Godoy A, Ulloa V, Rodriguez F, et al.Differential subcellular distribution of glucose transporters GLUT1-6 and GLUT9 in human cancer:ultrastructural localization of GLUTI and GLUT5 in breast tumor tissues [ J ].Cellular Physiology, 2006,207 ( 3 ) : 614-627.
  • 9Kalir T, Wang BY, Goldfischer M, et al.Immunohistochemical staining of GLUT1 in benign, borderline, and malignant ovarian epithelia [ J ].Cancer, 2002,94 ( 4 ) : 1078-1082.
  • 10Politi E, Kandaraki C, Apostlolopoulou C,et al.Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids [J ].Diagn Cytopathol,2005,32(3) : 151 - 155.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部